Literature DB >> 16203872

Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension.

Gil Salles1, Sharon Leocádio, Katia Bloch, Armando R Nogueira, Elizabeth Muxfeldt.   

Abstract

QT interval parameters have been associated with left ventricular hypertrophy (LVH) in hypertensive patients. The aim of this study is to assess this relationship in resistant hypertension and, in particular, to evaluate whether any QT interval parameter could provide additive information for LVH beyond that obtained from the best electrocardiographic voltage criterion. In a cross-sectional study, 471 resistant hypertensives were submitted to standard 12-lead ECGs, 24-hour ambulatory blood pressure monitoring, and 2D echocardiographic examinations. QT interval durations and QRS voltages were measured, and maximum rate-corrected QT interval duration (QTcmax) and dispersion (QTd), and Sokolow's and Cornell's voltage product were calculated. Statistical analyses involved bivariate tests and multivariate logistic regression, with LVH as the dependent variable. A total of 383 patients (81%) had echocardiographic LVH. In bivariate comparisons, both QT interval parameters showed a predictive performance for LVH similar to Cornell's product, the best ECG voltage criterion. In multivariate analysis, QT parameters and Cornell's product were independently associated with LVH, after adjustment for other LVH determinants. QTc interval >440 ms(1/2) and dispersion >60 ms were associated with a 2-fold (95% confidence interval [CI], 1.1 to 3.8) greater chance of having LVH, whereas Cornell's product >240 mV.ms implied a 2.6-fold (95% CI, 1.2 to 6.1) increased chance of LVH. The combination of prolonged QT interval and increased Cornell's product was associated with a 5.3- to 9.3-fold higher chance of having LVH. Hence, although in isolation, no QT interval parameter performs better for LVH detection than simpler Cornell's product, it provides additive information and can be used in combination with voltage criteria to refine LVH risk stratification in resistant hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16203872     DOI: 10.1161/01.HYP.0000185517.53179.43

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

1.  Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine Kinase.

Authors:  Polina Sysa-Shah; Lars L Sørensen; M Roselle Abraham; Kathleen L Gabrielson
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

2.  QT dispersion predicts mortality and correlates with both coronary artery calcification and atherosclerosis in hemodialysis patients.

Authors:  Murat Guney; Abdullah Ozkok; Yasar Caliskan; Hamdi Pusuroglu; Halil Yazici; Savas Tepe; Huseyin Oflaz; Alaattin Yildiz
Journal:  Int Urol Nephrol       Date:  2013-09-14       Impact factor: 2.370

3.  Inter-relationship between electrocardiographic left ventricular hypertrophy and QT prolongation as predictors of increased risk of mortality in the general population.

Authors:  Elsayed Z Soliman; Amit J Shah; Andrew Boerkircher; Yabing Li; Pentti M Rautaharju
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-04-24

4.  Interrelationship between electrocardiographic left ventricular hypertrophy, QT prolongation, and ischaemic stroke: the REasons for Geographic and Racial Differences in Stroke Study.

Authors:  Wesley T O'Neal; Virginia J Howard; Dawn Kleindorfer; Brett Kissela; Suzanne E Judd; Leslie A McClure; Mary Cushman; George Howard; Elsayed Z Soliman
Journal:  Europace       Date:  2015-10-20       Impact factor: 5.214

5.  Protein kinase C (PKC)ζ-mediated Gαq stimulation of ERK5 protein pathway in cardiomyocytes and cardiac fibroblasts.

Authors:  Carlota García-Hoz; Guzmán Sánchez-Fernández; Ramón García-Escudero; María Fernández-Velasco; Julia Palacios-García; Marisol Ruiz-Meana; Maria Teresa Díaz-Meco; Michael Leitges; Jorge Moscat; David García-Dorado; Lisardo Boscá; Federico Mayor; Catalina Ribas
Journal:  J Biol Chem       Date:  2012-01-09       Impact factor: 5.157

6.  Serum 25-hydroxyvitamin D, calcium, phosphorus, and electrocardiographic QT interval duration: findings from NHANES III and ARIC.

Authors:  Yiyi Zhang; Wendy S Post; Darshan Dalal; Sandeep Bansal; Elena Blasco-Colmenares; Suzanne Jan De Beur; Alvaro Alonso; Elsayed Z Soliman; Eric A Whitsel; Ramón Brugada; Gordon F Tomaselli; Eliseo Guallar
Journal:  J Clin Endocrinol Metab       Date:  2011-04-20       Impact factor: 5.958

7.  Electrocardiographic criteria for left ventricular hypertrophy in children.

Authors:  Peter R Rijnbeek; Gerard van Herpen; Livia Kapusta; A Derk Jan Ten Harkel; Maarten Witsenburg; Jan A Kors
Journal:  Pediatr Cardiol       Date:  2008-04-25       Impact factor: 1.655

8.  Clinical correlates and heritability of QT interval duration in blacks: the Jackson Heart Study.

Authors:  Ermeg L Akylbekova; Richard S Crow; William D Johnson; Sarah G Buxbaum; Stephanie Njemanze; Ervin Fox; Daniel F Sarpong; Herman A Taylor; Christopher Newton-Cheh
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-05-27

Review 9.  Cardiovascular and renal complications in patients with resistant hypertension.

Authors:  Elizabeth S Muxfeldt; Fabio de Souza; Victor S Margallo; Gil F Salles
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

10.  Screening for primary aldosteronism in a cohort of Brazilian patients with resistant hypertension.

Authors:  Armando R Nogueira; Katia V Bloch
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-08       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.